全文获取类型
收费全文 | 415篇 |
免费 | 28篇 |
国内免费 | 14篇 |
专业分类
儿科学 | 17篇 |
妇产科学 | 5篇 |
基础医学 | 39篇 |
口腔科学 | 5篇 |
临床医学 | 27篇 |
内科学 | 106篇 |
皮肤病学 | 1篇 |
神经病学 | 23篇 |
特种医学 | 58篇 |
外科学 | 41篇 |
综合类 | 33篇 |
预防医学 | 13篇 |
眼科学 | 2篇 |
药学 | 12篇 |
中国医学 | 1篇 |
肿瘤学 | 74篇 |
出版年
2023年 | 4篇 |
2022年 | 2篇 |
2021年 | 14篇 |
2020年 | 6篇 |
2019年 | 16篇 |
2018年 | 12篇 |
2017年 | 9篇 |
2016年 | 7篇 |
2015年 | 11篇 |
2014年 | 16篇 |
2013年 | 33篇 |
2012年 | 31篇 |
2011年 | 21篇 |
2010年 | 17篇 |
2009年 | 15篇 |
2008年 | 23篇 |
2007年 | 20篇 |
2006年 | 18篇 |
2005年 | 19篇 |
2004年 | 6篇 |
2003年 | 8篇 |
2002年 | 9篇 |
2001年 | 11篇 |
2000年 | 6篇 |
1999年 | 2篇 |
1998年 | 11篇 |
1997年 | 6篇 |
1996年 | 9篇 |
1995年 | 7篇 |
1994年 | 5篇 |
1993年 | 9篇 |
1992年 | 6篇 |
1991年 | 3篇 |
1990年 | 6篇 |
1989年 | 8篇 |
1988年 | 4篇 |
1987年 | 3篇 |
1985年 | 6篇 |
1984年 | 3篇 |
1983年 | 4篇 |
1982年 | 2篇 |
1981年 | 3篇 |
1980年 | 4篇 |
1979年 | 3篇 |
1978年 | 3篇 |
1977年 | 3篇 |
1975年 | 2篇 |
1964年 | 2篇 |
1962年 | 1篇 |
1961年 | 3篇 |
排序方式: 共有457条查询结果,搜索用时 15 毫秒
441.
Amyopathic Dermatomyositis and Pulmonary Fibrosis 总被引:1,自引:0,他引:1
‘Amyotrophic dermatomyositis’ (ADM) is used to describe a small subgroup of patients with the typical skin rash associated
with dermatomyositis but without muscle involvement. Lung involvement in ADM is rare. We report on the management of a patient
with ADM associated with pulmonary fibrosis at presentation, and her response to corticosteroid treatment.
Received: 14 September 1999 / Accepted: 18 April 2000 相似文献
442.
Heise T Nosek L Ronn BB 《药品评价》2008,5(10):437-437
此随机、双盲研究旨在比较地特胰岛素与甘精胰岛素和NPH在1型糖尿病患者中降糖疗效受试者个体内的变异性。54名受试者(32名男性和22名女性,年龄38±10岁,BMI24±2kg/m^2, 相似文献
443.
Assunta De Rienzo Lucian R Chirieac Yin P Hung David T Severson Samuel Freyaldenhoven Corinne E Gustafson Nhien T Dao Claire V Meyerovitz Michela E Oster Roderick V Jensen Beow Y Yeap Raphael Bueno William G Richards 《The Journal of pathology》2021,253(1):68-79
BRCA1‐associated protein‐1 (BAP1) expression is commonly lost in several tumors including malignant pleural mesothelioma (MPM). Presence or absence of immunohistochemical BAP1 nuclear staining in tumor cells is currently used for differential diagnosis of MPM. In this study, a large cohort of 596 MPM tumors with available clinical data was analyzed to examine associations of BAP1 staining pattern with clinical and molecular features that may reflect the impact of BAP1 mutation on MPM biology. Cases were classified according to the BAP1 staining pattern of tumor cells. Exome and RNA‐sequencing data were available for subsets of cases. Levels of mRNA encoding claudin 15 (CLDN15) and vimentin (VIM) were determined using RT‐qPCR on 483 cases to estimate the relative proportions of epithelial‐like and mesenchymal‐like components in each tumor. Four BAP1 staining patterns were observed: single‐pattern nuclear staining (36%), single‐pattern cytoplasmic staining (25%), single‐pattern absent staining (12%), and combinations of these staining patterns (27%). This study confirmed prior reports that nuclear BAP1 is more frequently associated with wild‐type BAP1 and sarcomatoid histology. However, no associations between BAP1 staining pattern(s) and mutations in specific protein domains and/or mutation type were observed. BAP1 staining patterns were significantly associated (p < 0.001) with BAP1 gene expression, MPM histologic subtypes, molecular clusters, and markers of epithelial‐to‐mesenchymal transition. Frequent observation of combinations of BAP1 staining patterns in MPM tumors indicated intra‐tumoral heterogeneity of BAP1 status. Cytoplasmic BAP1 staining was identified as a putative indicator of favorable prognosis in non‐epithelioid MPM. In conclusion, novel significant associations among different BAP1 staining patterns and subgroups of MPM tumors were observed, suggesting that the role of BAP1 in tumor progression may be more complex than its presumed tumor suppressor function. Cytoplasmic staining was identified as a putative indicator of favorable prognosis in non‐epithelioid MPM, potentially addressing a critical need in clinical decision‐making in this disease. © 2020 The Authors. The Journal of Pathology published by John Wiley & Sons, Ltd. on behalf of The Pathological Society of Great Britain and Ireland. 相似文献
444.
Nicole J. Look Hong MD MSc Francis J. Hornicek MD PhD Kevin A. Raskin MD Sam S. Yoon MD Jackie Szymonifka MS Beow Yeap ScD Yen-Lin Chen MD Thomas F. DeLaney MD G. Petur Nielsen MD John T. Mullen MD 《Annals of surgical oncology》2013,20(1):80-86
Background
Myxofibrosarcomas (MFS) are a historically heterogeneous group of tumors that exhibit a propensity for local recurrence. The objectives of this study were to analyze the prognostic factors and outcomes of patients with MFS treated at a single institution.Methods
We retrospectively reviewed the records of 69 consecutive patients with pathologically confirmed MFS of the extremities or superficial trunk who underwent surgery from August 1995 to November 2010. Clinicopathologic features, treatments, and patient outcomes were reviewed.Results
Sixty-nine patients were identified, of whom 38 were men (55 %). The median age was 62 years. Sixty-four patients (93 %) presented with primary tumors, and 5 patients (7 %) presented with locally recurrent tumors. Median tumor size was 6.0 cm, and 44 patients (64 %) had grade 3 tumors (FNCLCC [Fédération Nationale des Centres de Lutte Contre le Cancer] classification). Margins were microscopically positive in 14 patients (20 %) and negative in 55 patients (80 %), including close margins (<1 mm) in 14 patients (20 %). Fifty-three patients (77 %) received radiotherapy. At a median follow-up of 41 months, there were 11 local (16 %) and 11 distant (16 %) recurrences. The local and distant 5-year recurrence-free survival rates were 72 % and 82 %, and the 5-year overall survival was 61 %. Increased age (scaled by 0.1; hazard ratio [HR] 1.80, P = 0.002) and tumor size (HR 1.12, P = 0.004) were negatively correlated with overall survival. Positive/close (<1 mm) margin status (HR 4.34, P = 0.030) predicted worsened local recurrence-free survival.Conclusions
MFS exhibit a propensity for local recurrence, which is predicted by resection with positive or close margins. Aggressive surgery combined with radiotherapy may contribute to more effective local control. 相似文献445.
446.
Prognostic significance of treatment‐induced pathologic necrosis in extremity and truncal soft tissue sarcoma after neoadjuvant chemoradiotherapy
下载免费PDF全文
![点击此处可从《Cancer》网站下载免费的PDF全文](/ch/ext_images/free.gif)
447.
448.
F Feng K Akiyama Y Liu T Yamaza T-M Wang J-H Chen BB Wang G T-J Huang S Wang S Shi 《Oral diseases》2010,16(1):20-28
Objective: Periodontal disease is an inflammatory disorder with widespread morbidities involving both oral and systemic health. The primary goal of periodontal treatment is the regeneration of the lost or diseased periodontium. In this study, we retrospectively examined feasibility and safety of reconstructing the periodontal intrabony defects with autologous periodontal ligament progenitor (PDLP) implantation in three patients.
Materials and methods: In this retrospective pilot study, we treated 16 teeth with at least one deep intrabony defect of probing depth (PD) ≥ 6 mm with PDLP transplantation and evaluated clinical outcome measures in terms of probing depth, gingival recession and attachment gain for a duration of 32–72 months. Furthermore, we compare PDLPs with standard PDL stem cells (PDLSCs) and confirmed that PDLPs possessed progenitor characters.
Results: Clinical examination indicated that transplantation of PDLPs may provide therapeutic benefit for the periodontal defects. All treated patients showed no adverse effects during the entire course of follow up. We also found that PDLPs were analogous to PDLSCs in terms of high proliferation, expression of mesenchymal surface molecules, multipotent differentiation, and in vivo tissue regain. However, PDLPs failed to express scleraxis, a marker of tendon, as seen in PDLSCs.
Conclusions: This study demonstrated clinical and experimental evidences supporting a potential efficacy and safety of utilizing autologous PDL cells in the treatment of human periodontitis. 相似文献
Materials and methods: In this retrospective pilot study, we treated 16 teeth with at least one deep intrabony defect of probing depth (PD) ≥ 6 mm with PDLP transplantation and evaluated clinical outcome measures in terms of probing depth, gingival recession and attachment gain for a duration of 32–72 months. Furthermore, we compare PDLPs with standard PDL stem cells (PDLSCs) and confirmed that PDLPs possessed progenitor characters.
Results: Clinical examination indicated that transplantation of PDLPs may provide therapeutic benefit for the periodontal defects. All treated patients showed no adverse effects during the entire course of follow up. We also found that PDLPs were analogous to PDLSCs in terms of high proliferation, expression of mesenchymal surface molecules, multipotent differentiation, and in vivo tissue regain. However, PDLPs failed to express scleraxis, a marker of tendon, as seen in PDLSCs.
Conclusions: This study demonstrated clinical and experimental evidences supporting a potential efficacy and safety of utilizing autologous PDL cells in the treatment of human periodontitis. 相似文献
449.
450.